Stocks
Funds
Screener
Sectors
Watchlists

Latest AlphaCentric Advisors LLC Stock Portfolio

AlphaCentric Advisors LLC Performance:
2024 Q3: 4.64%YTD: -3.53%2023: -6.69%

Performance for 2024 Q3 is 4.64%, and YTD is -3.53%, and 2023 is -6.69%.

About AlphaCentric Advisors LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, AlphaCentric Advisors LLC reported an equity portfolio of $134.5 Millions as of 30 Sep, 2024.

The top stock holdings of AlphaCentric Advisors LLC are RITM, HRMY, . The fund has invested 3.2% of it's portfolio in RITHM CAPITAL CORP and 2.9% of portfolio in HARMONY BIOSCIENCES HLDGS IN.

The fund managers got completely rid off BIOCRYST PHARMACEUTICALS INC (BCRX), PACIRA BIOSCIENCES INC (PCRX) and UNIQURE NV (QURE) stocks. They significantly reduced their stock positions in TOURMALINE BIO INC, VIKING THERAPEUTICS INC (VKTX) and PFIZER INC (PFE). AlphaCentric Advisors LLC opened new stock positions in MERCK & CO INC (MRK), INDIVIOR PLC and ALPHATEC HLDGS INC (ATEC). The fund showed a lot of confidence in some stocks as they added substantially to CINTAS CORP (CTAS), NEUROCRINE BIOSCIENCES INC (NBIX) and SAREPTA THERAPEUTICS INC (SRPT).

AlphaCentric Advisors LLC Annual Return Estimates Vs S&P 500

Our best estimate is that AlphaCentric Advisors LLC made a return of 4.64% in the last quarter. In trailing 12 months, it's portfolio return was -1.01%.

New Buys

Ticker$ Bought
merck & co inc2,725,440
indivior plc2,364,380
alphatec hldgs inc2,057,200
apellis pharmaceuticals inc1,369,900
takeda pharmaceutical co ltd1,137,600
lantheus hldgs inc987,750
penumbra inc777,240
nuvalent inc716,100

New stocks bought by AlphaCentric Advisors LLC

Additions to existing portfolio by AlphaCentric Advisors LLC

Reductions

Ticker% Reduced
tourmaline bio inc-92.67
arrivent biopharma inc-82.56
viking therapeutics inc-78.79
pfizer inc-75.00
medtronic plc-71.43
coherus biosciences inc-67.00
beigene ltd-63.33
acadia pharmaceuticals inc-60.00

AlphaCentric Advisors LLC reduced stake in above stock

Sold off

Ticker$ Sold
rwt hldgs inc-975,041
biocryst pharmaceuticals inc-4,171,500
docgo inc-2,008,500
redwood trust inc-485,938
uniqure nv-2,060,800
pacira biosciences inc-3,361,680
aurinia pharmaceuticals inc-456,800
cabaletta bio inc-523,600

AlphaCentric Advisors LLC got rid off the above stocks

Sector Distribution

AlphaCentric Advisors LLC has about 45.6% of it's holdings in Healthcare sector.

Sector%
Healthcare45.6
Others24.9
Real Estate14.4
Financial Services5.6
Industrials4.1
Technology2.9
Consumer Cyclical1.1

Market Cap. Distribution

AlphaCentric Advisors LLC has about 26.8% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED24.9
MID-CAP24
LARGE-CAP22.3
SMALL-CAP19.3
MICRO-CAP4.6
MEGA-CAP4.5

Stocks belong to which Index?

About 45.1% of the stocks held by AlphaCentric Advisors LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others54.8
RUSSELL 200032.3
S&P 50012.8
Top 5 Winners (%)%
RVNC
revance therapeutics inc
102.0 %
VRDN
viridian therapeutics inc
70.2 %
RKLB
rocket lab usa inc
67.2 %
EXAS
exact sciences corp
61.2 %
APP
applovin corp
55.5 %
Top 5 Winners ($)$
HRMY
harmony biosciences hldgs in
1.1 M
BGNE
beigene ltd
0.9 M
EXAS
exact sciences corp
0.8 M
RVNC
revance therapeutics inc
0.6 M
MTG
mgic invt corp wis
0.5 M
Top 5 Losers (%)%
CTAS
cintas corp
-72.2 %
SMCI
super micro computer inc
-48.2 %
ESTC
elastic n v
-31.9 %
PGNY
progyny inc
-28.6 %
CHRS
coherus biosciences inc
-27.6 %
Top 5 Losers ($)$
NBIX
neurocrine biosciences inc
-0.6 M
CTAS
cintas corp
-0.5 M
CHRS
coherus biosciences inc
-0.5 M
BMRN
biomarin pharmaceutical inc
-0.4 M
APLS
apellis pharmaceuticals inc
-0.4 M

AlphaCentric Advisors LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of AlphaCentric Advisors LLC

AlphaCentric Advisors LLC has 227 stocks in it's portfolio. About 21.5% of the portfolio is in top 10 stocks. NBIX proved to be the most loss making stock for the portfolio. HRMY was the most profitable stock for AlphaCentric Advisors LLC last quarter.

Last Reported on: 30 Oct, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions